Resource Consulting Group’s AbbVie ABBV Stock Holding History

Resource Consulting Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.29M	Hold	8,339	–	–	0.22%	27
2023 Q3	$1.24M	Sell	8,339 -388	-4%	-$57K	0.24%	24
2023 Q2	$1.18M	Buy	+8,727	New	+$1.28M	0.23%	29
2022 Q3	–	Sell	-5,832	Closed	-$893K	–	48
2022 Q2	$893K	Sell	5,832 -33	-0.6%	-$5.04K	0.38%	16
2022 Q1	$951K	Hold	5,865	–	–	0.33%	26
2021 Q4	$794K	Buy	+5,865	New	+$693K	0.28%	32

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Resource Consulting Group's ABBV Position: Q4 2023 in Review

Resource Consulting Group held its AbbVie (ABBV) position steady in Q4 2023 at 8,339 shares worth $1.29M. The position accounts for 0.22% of the portfolio, ranked #27.

Resource Consulting Group first reported a position in ABBV in Q4 2021 and has held it in 6 quarters since. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Resource Consulting Group held 8,339 shares of AbbVie worth $1.29M as of Q4 2023.
Resource Consulting Group left its AbbVie share count unchanged in Q4 2023.
AbbVie made up 0.22% of Resource Consulting Group's portfolio in Q4 2023, its #27 holding.
Resource Consulting Group first reported a position in AbbVie in Q4 2021 and has held it in 6 quarters since.
3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Resource Consulting Group's 13F filing for Q4 2023, filed 11 Jan 2024.